Pathologic determinants of ctDNA-shedding in colorectal cancer metastases.

View at publisher
Authors: Hiroki Yukami, Hideaki Bando, Yu Aoki, Yuki Matsubara, Takeshi Kuwata, Shingo Sakashita, Yujiro Nishizawa, Yoshinori Kagawa, Yasuhiro Yonezuka, Masahiro Nishida, Yuka Oi, Naoki Akiyama
+6 more Shin Kobayashi, Naoto Gotohda, Keiju Aokage, Masahiro Tsuboi, Jesús García‐Foncillas, Takayuki Yoshino
Cited by: 0

Abstract

183 Background: In colorectal cancer (CRC), the concordance of genomic alterations between plasma-derived ctDNA and matched tumor tissue is lower in patients with lung-only metastases than in those with liver metastases. This suggests that organ-related and histopathologic characteristics may influence ctDNA-shedding. We therefore aimed to investigate which histopathologic factors are associated with ctDNA-shedding. Methods: This prospective study included patients who had undergone resection of the primary site of CRC and were scheduled for lung or liver metastasectomy. Plasma was collected immediately before surgery for ctDNA analysis of 12 genes commonly altered in CRC, using the Plasma-Safe-SeqS CRC assay (Sysmex, Kobe, Japan). To determine whether detected alterations were tumor-derived, matched tissue samples were also analyzed using an NGS-based panel assay. Cases with mutations detected in both tissue and plasma were defined as ctDNA-shedding, those with mutations in tissue but not in plasma as ctDNA-non-shedding, and cases without tissue mutations were considered non-mutated and excluded from the analysis. Digital pathology quantified metastatic size, necrosis area, total tumor-cell count, and cell density using HALO Image Analysis Platform. ROC curves were used to determine cutoff values for each factor, and factors associated with ctDNA-shedding were evaluated. Results: Among 37 analyzable cases (lung=26, liver=11), ctDNA-shedding was observed in 13 (35.1%). Detection differed by organ: lung 4/26 (15.4%) vs liver 9/11 (81.8%). ROC analyses yielded the following cutoffs (AUC): size 15.0 mm (AUC 0.877), necrosis area 19.822 mm² (AUC 0.869), total tumor-cell count 552,471 (AUC 0.881), density 7,834.418 (AUC 0.671). Multivariate analysis including these factors and organ site identified necrosis area as significantly associated with ctDNA-shedding (P=0.0292). Correlation coefficient analysis with plasma mutant allele fraction (MAF) showed significant associations for necrosis area (P

Fields of Study & Subjects

Cancer Genomics and Diagnostics Colorectal Cancer Treatments and Studies Genetic factors in colorectal cancer

Publication details

Journal / source
Journal of Clinical Oncology
Volume
44
Issue
2_suppl
Pages
183–183
Publication date
10 January 2026
Language
EN